The University of Texas Health Science Center at the Houston Medical School led by Charles Cox, M.D. of the Children’s Fund, Inc. has started its research on the effectiveness on two forms of stem cell treatment for children with cerebral palsy. The study seeks to compare the difference of using banked cord blood from bone marrow stem cells when doing treatment.
Scientists will study 30 children afflicted with cerebral palsy between the ages of 2 and 10 admitted to the Children’s Memorial Hermann and Memorial Hermann-Texas Medical Center. Parents of these children will not be informed whether their child was given a placebo or the stem cell “treatment” until they come in for their 12 month follow-up exam.
Prevalent treatments for children with cerebral palsy include medications; physical, occupational, and speech therapy; and braces.
Cox is also studying the possibility of using blood stem cell treatment for traumatic brain injuries in another set of clinical trials.
Cerebral palsy is a disorder closely linked to the brain or nervous children and affects the development of motor control in children, altering their life and functionality. Should your child develop this condition due to the negligent actions of a medical practitioner, our attorneys at The Driscoll Firm can help you explore your legal options. Find out more by calling (800) 900-7704 today.
Researchers at Duke University have established a clinical trial in order to help treat cerebral palsy in young children.
Currently, there is no cure for cerebral palsy, which is a disorder that can develop at birth due to medical malpractice. If a child is deprived of oxygen during birth, his or her brain may suffer from damage, potentially leading to brain and nervous system issues resulting in physical and mental disabilities.
The clinical trial is looking at using a child’s own cord blood as a solution to help treat the symptoms of spastic cerebral palsy. Children between the ages of 1 and 6 are able to participate in the trial if they have a supply of their own cord blood. The blood is injected intravenously, and there is no chance of rejection due to it being the child’s own blood.
The doctors conducting this trial are hopeful that this method could improve the debilitating complications that develop in children with cerebral palsy. If the trial proves to be a success, then the doctors have stated their plans to move forward with using the cord blood to prevent the chronic condition altogether.